Literature DB >> 25254964

Connecting gene expression data from connectivity map and in silico target predictions for small molecule mechanism-of-action analysis.

Aakash Chavan Ravindranath1, Nolen Perualila-Tan, Adetayo Kasim, Georgios Drakakis, Sonia Liggi, Suzanne C Brewerton, Daniel Mason, Michael J Bodkin, David A Evans, Aditya Bhagwat, Willem Talloen, Hinrich W H Göhlmann, Ziv Shkedy, Andreas Bender.   

Abstract

Integrating gene expression profiles with certain proteins can improve our understanding of the fundamental mechanisms in protein-ligand binding. This paper spotlights the integration of gene expression data and target prediction scores, providing insight into mechanism of action (MoA). Compounds are clustered based upon the similarity of their predicted protein targets and each cluster is linked to gene sets using Linear Models for Microarray Data. MLP analysis is used to generate gene sets based upon their biological processes and a qualitative search is performed on the homogeneous target-based compound clusters to identify pathways. Genes and proteins were linked through pathways for 6 of the 8 MCF7 and 6 of the 11 PC3 clusters. Three compound clusters are studied; (i) the target-driven cluster involving HSP90 inhibitors, geldanamycin and tanespimycin induces differential expression for HSP90-related genes and overlap with pathway response to unfolded protein. Gene expression results are in agreement with target prediction and pathway annotations add information to enable understanding of MoA. (ii) The antipsychotic cluster shows differential expression for genes LDLR and INSIG-1 and is predicted to target CYP2D6. Pathway steroid metabolic process links the protein and respective genes, hypothesizing the MoA for antipsychotics. A sub-cluster (verepamil and dexverepamil), although sharing similar protein targets with the antipsychotic drug cluster, has a lower intensity of expression profile on related genes, indicating that this method distinguishes close sub-clusters and suggests differences in their MoA. Lastly, (iii) the thiazolidinediones drug cluster predicted peroxisome proliferator activated receptor (PPAR) PPAR-alpha, PPAR-gamma, acyl CoA desaturase and significant differential expression of genes ANGPTL4, FABP4 and PRKCD. The targets and genes are linked via PPAR signalling pathway and induction of apoptosis, generating a hypothesis for the MoA of thiazolidinediones. Our analysis show one or more underlying MoA for compounds and were well-substantiated with literature.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25254964     DOI: 10.1039/c4mb00328d

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  10 in total

Review 1.  A review of connectivity map and computational approaches in pharmacogenomics.

Authors:  Aliyu Musa; Laleh Soltan Ghoraie; Shu-Dong Zhang; Galina Glazko; Olli Yli-Harja; Matthias Dehmer; Benjamin Haibe-Kains; Frank Emmert-Streib
Journal:  Brief Bioinform       Date:  2018-05-01       Impact factor: 11.622

2.  Development and validation of an RNA-seq-based transcriptomic risk score for asthma.

Authors:  Xuan Cao; Lili Ding; Tesfaye B Mersha
Journal:  Sci Rep       Date:  2022-05-23       Impact factor: 4.996

3.  Cheminformatics Research at the Unilever Centre for Molecular Science Informatics Cambridge.

Authors:  Julian E Fuchs; Andreas Bender; Robert C Glen
Journal:  Mol Inform       Date:  2015-03-10       Impact factor: 3.353

4.  Transcriptomic study on the impact of temporomandibular joint internal derangement in the condylar cartilage of rabbits.

Authors:  Shuhua Wang; Gaoli Xu; Liquan Deng; Zhiyuan Gu
Journal:  Genom Data       Date:  2015-07-11

5.  The Utility of Resolving Asthma Molecular Signatures Using Tissue-Specific Transcriptome Data.

Authors:  Debajyoti Ghosh; Lili Ding; Jonathan A Bernstein; Tesfaye B Mersha
Journal:  G3 (Bethesda)       Date:  2020-11-05       Impact factor: 3.154

6.  Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition.

Authors:  Haoxin Li; Andrew Cowie; John A Johnson; Duncan Webster; Christopher J Martyniuk; Christopher A Gray
Journal:  BMC Genomics       Date:  2016-08-11       Impact factor: 3.969

7.  Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery.

Authors:  Zhilong Jia; Ying Liu; Naiyang Guan; Xiaochen Bo; Zhigang Luo; Michael R Barnes
Journal:  BMC Genomics       Date:  2016-05-27       Impact factor: 3.969

8.  Apigenin enhances skeletal muscle hypertrophy and myoblast differentiation by regulating Prmt7.

Authors:  Young Jin Jang; Hyo Jeong Son; Yong Min Choi; Jiyun Ahn; Chang Hwa Jung; Tae Youl Ha
Journal:  Oncotarget       Date:  2017-09-16

9.  Comparing structural and transcriptional drug networks reveals signatures of drug activity and toxicity in transcriptional responses.

Authors:  Francesco Napolitano; Sandra Pisonero-Vaquero; Francesco Sirci; Diego Carrella; Diego L Medina; Diego di Bernardo
Journal:  NPJ Syst Biol Appl       Date:  2017-08-25

10.  Repurposing Drugs by In Silico Methods to Target BCR Kinase Domain in Chronic Myeloid Leukemia.

Authors:  Aparna Natarajan; Rajkumar Thangarajan; Sabitha Kesavan
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.